Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Yohann Loriot, MD, PhD
Yohann Loriot, MD, PhD
  • Physician Scientist
  • Director of Bladder Cancer Program
  • Gustave Roussy; Université Paris-Saclay
  • Villejuif, France
Dr. Loriot’s major research focus involves the study of molecular mechanisms mediating progression to lethal disease in bladder and prostate cancer and use of these informations to develop novel new strategies and therapies. Dr Loriot is currently member of steering committee of multiple international clinical trials from phase I to phase III leading him to be co-author of collaborative work (published in N Engl J Med, Nature, Lancet Oncology, European Urology, J Clin Oncol). He has been involved in trials leading to several drug approvals (enzalutamide, abiraterone, atezolizumab). He’s now developping ancillary studies to better understand the mechanisms of actions and resistance to these new drugs (targeted therapies and checkpoints inhibitors) (MATCH-R study)
Programs 4/21/21